Dark Forest Capital Management LP Amneal Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.97 - $8.23 $2.37 Million - $2.8 Million	-340,667 Reduced 68.17%	159,040 $1.29 Million
Q1 2025 May 15, 2025	BUY	$7.72 - $9.01 $3.74 Million - $4.37 Million	484,818 Added 3256.22%	499,707 $4.19 Million
Q4 2024 Feb 14, 2025	BUY	$7.69 - $9.25 $5,798 - $6,974	754 Added 5.33%	14,889 $117,000
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $90,746 - $124,812	14,135 New	14,135 $117,000

257

150M

357K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.